Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04501016Phase 3Not yet recruiting
A Phase 3 trial of nicotine patch, bupropion, varenicline + nicotine patch in Tobacco Use Disorder (TUD), sponsored by Iowa City VA Health Care System. Planned start Sep 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04501016.